Related Experiment Video
Updated: Feb 3, 2026

Author Spotlight: Advancing Hematopoietic Research Using Stromal Cell Isolation for Single Cell Sequencing
Published on: January 26, 2024
Dysregulation of Nrf2/Keap1 Redox Pathway in Diabetes Affects Multipotency of Stromal Cells
Piul S Rabbani1, Marc A Soares2, Sophia G Hameedi2
1Hansjörg Wyss Department of Plastic Surgery, New York University School of Medicine, New York, NY piul.rabbani@nyumc.org daniel.ceradini@nyumc.org.
Abstract:
The molecular and cellular level reaches of the metabolic dysregulations that characterize diabetes are yet to be fully discovered. As mechanisms underlying management of reactive oxygen species (ROS) gain interest as crucial factors in cell integrity, questions arise about the role of redox cues in the regulation and maintenance of bone marrow-derived multipotent stromal cells (BMSCs) that contribute to wound healing, particularly in diabetes. Through comparison of BMSCs from wild-type and diabetic mice, with a known redox and metabolic disorder, we found that the cytoprotective nuclear factor erythroid-related factor 2 (Nrf2)/kelch-like erythroid cell-derived protein 1 (Keap1) pathway is dysregulated and functionally insufficient in diabetic BMSCs (dBMSCs). Nrf2 is basally active, but in chronic ROS, we found irregular inhibition of Nrf2 by Keap1, altered metabolism, and limited BMSC multipotency. Forced upregulation of Nrf2-directed transcription, through knockdown of Keap1, restores redox homeostasis. Normalized Nrf2/Keap1 signaling restores multipotent cell properties in dBMSCs through Sox2 expression. These restored BMSCs can resume their role in regenerative tissue repair and promote healing of diabetic wounds. Knowledge of diabetes and hyperglycemia-induced deficits in BMSC regulation, and strategies to reverse them, offers translational promise. Our study establishes Nrf2/Keap1 as a cytoprotective pathway, as well as a metabolic rheostat, that affects cell maintenance and differentiation switches in BMSCs.
Insights
Diabetic bone marrow cells show impaired wound healing due to redox imbalance. Restoring the Nrf2/Keap1 pathway improves cell function and promotes diabetic wound repair.
Area of Science:
- Biomedical Science
- Cell Biology
- Metabolic Research
Background:
- Diabetes mellitus is characterized by metabolic dysregulation impacting cellular functions.
- Reactive oxygen species (ROS) management is critical for cell integrity and wound healing.
- Bone marrow-derived multipotent stromal cells (BMSCs) play a key role in tissue regeneration.
Purpose of the Study:
- To investigate the role of redox signaling in diabetic BMSC regulation and function.
- To identify molecular mechanisms underlying impaired wound healing in diabetes.
- To explore therapeutic strategies targeting redox pathways in diabetic BMSCs.
Main Methods:
- Comparative analysis of BMSCs from wild-type and diabetic mice.
- Investigation of the nuclear factor erythroid-related factor 2 (Nrf2)/kelch-like erythroid cell-derived protein 1 (Keap1) pathway.
- Manipulation of Nrf2/Keap1 signaling via Keap1 knockdown.
- Assessment of BMSC multipotency and Sox2 expression.
Main Results:
- Diabetic BMSCs exhibit dysregulated and insufficient Nrf2/Keap1 pathway activity.
- Chronic ROS in diabetic BMSCs leads to altered metabolism and reduced multipotency.
- Knockdown of Keap1 restores redox homeostasis and Nrf2/Keap1 signaling.
- Restored signaling normalizes BMSC multipotency via Sox2 expression.
Conclusions:
- The Nrf2/Keap1 pathway is a critical regulator of BMSC maintenance and differentiation, acting as a metabolic rheostat.
- Dysregulation of Nrf2/Keap1 contributes to impaired wound healing in diabetes.
- Targeting the Nrf2/Keap1 pathway offers translational potential for treating diabetic complications.
Related Concept Videos
Balancing Redox Equations
Redox Reactions
Redox Reactions
Multipotency of Hematopoietic Stem Cells
Multipotency and Niche of Bulge Stem Cell
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...

